Artificial Intelligence Paves the Way for New Software to Help Detect and Diagnose Wrist Fractures

The U.S. Food and Drug Administration (FDA) recently gave the green light on the marketing of a computer-aided software that can detect and diagnose wrist fractures. This is the next step in the advancement of artificial intelligence for medical practice. However, as the FDA’s official press release notes, this program should not be used in place of official clinical diagnose. But rather, the device is intended to be used as an “adjunct tool.”

The software, called OsteoDetect, uses an artificial intelligence algorithm to analyze two-dimensional x-rays to identify a common type of wrist fracture. The software also pinpoints the location of the fracture on the x-ray to assist the medical provider in locating and treating the injury more expediently.

For further information, click here: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm608833.htm